|1.||Focal Epithelial Hyperplasia
|1.||Akpolat, Demet: 1 article (02/2015)|
|2.||Metin, Ahmet: 1 article (02/2015)|
|3.||Emre, Selma: 1 article (02/2015)|
|4.||Süngü, Nuran: 1 article (02/2015)|
|5.||Akoğlu, Gülşen: 1 article (02/2015)|
|6.||Ceylan, Gülay Güleç: 1 article (02/2015)|
|7.||Myoung, Hoon: 1 article (12/2014)|
|8.||Cho, Young-Ah: 1 article (12/2014)|
|9.||Kim, Soung-Min: 1 article (12/2014)|
|10.||Park, Min-Woo: 1 article (12/2014)|
|1.||DNA (Deoxyribonucleic Acid)IBA
11/01/2011 - "Oral focal epithelial hyperplasia: report of 3 cases with human papillomavirus DNA sequencing analysis."
01/01/2006 - "This report describes the diagnosis of focal epithelial hyperplasia in five Central Amazonian Indians who sought treatment at the Amazonas State Foundation of Tropical Medicine (FMT-AM), using clinical criteria, polymerase chain reaction (PCR) and DNA sequencing."
05/01/1991 - "Human papillomavirus (HPV) DNA in focal epithelial hyperplasia by in situ hybridization."
03/01/1989 - "Detection of human papillomavirus (HPV) DNA in focal epithelial hyperplasia."
12/01/1987 - "A significant cross-hybridization has been observed between the DNA of HPV42 and that of HPV32, the latter being associated with oral focal epithelial hyperplasia. "
02/01/2015 - "Focal epithelial hyperplasia associated with human papillomavirus 13 and common human leukocyte antigen alleles in a Turkish family."
09/01/1985 - "Immunohistochemical evidence of papillomavirus antigen in focal epithelial hyperplasia."
06/01/1983 - "Six oral squamous cell tumours classified as focal epithelial hyperplasia (FEH), Condyloma acuminatum (CA) and squamous cell papilloma (SQP) were subjected to indirect immunoperoxidase staining with anti-human papillomavirus (anti-HPV) antiserum to demonstrate the possible presence of HPV antigens in these lesions. "
01/01/1987 - "A total of 54/206 (26.2%) lesions were observed to express HPV antigens, being found in 45/92 (48.9%) of the squamous cell papillomas/condylomas, in 1/54 fibrous hyperplasias, in 1/8 true fibromas, and in 7/8 (87.5%) of the focal epithelial hyperplasia (FEH) lesions. "
05/01/1991 - "Eighteen cases of focal epithelial hyperplasia (FEH) were investigated for the presence of human papillomavirus (HPV) group specific antigen by immunocytochemistry and HPV types 1, 6, 11, 13, 16, 18 and 32 by DNA in situ hybridization employing biotinylated probes. "
|3.||imiquimod (Aldara)FDA LinkGeneric
07/01/2009 - "Here we report three children of Turkish origin with focal epithelial hyperplasia successfully treated with imiquimod 5% cream. "
07/01/2009 - "Treatment of focal epithelial hyperplasia with topical imiquimod: report of three cases."
03/01/2010 - "Focal epithelial hyperplasia (Heck's Disease) in two siblings: response to treatment with imiquimod 5% cream."
10/01/2004 - "[Imiquimod for the topical treatment of focal epithelial hyperplasia (Heck disease) in a child]."
01/01/1992 - "In situ hybridization with digoxigenin-labelled DNA probes for the detection of human papillomavirus-induced focal epithelial hyperplasia among Venezuelans."
08/01/1989 - "17 cases of focal epithelial hyperplasia of the oral mucosa (FEH, Heck's disease) were investigated for the presence of human papillomavirus (HPV) nucleic acid sequences by means of in situ DNA hybridization using biotinylated DNA probes of HPV types 1, 6, 11, 13, 16, 18, and 32. "
|5.||Naphthol AS D Esterase (ANAE)IBA
01/01/1983 - "The immunocompetent cells (B and T lymphocytes, mononuclear phagocytes, MPS cells) known to be responsible for the rejection of the HPV- (Human Papillomavirus) induced tumors in the skin (warts) were analyzed in the infiltrates of 63 oral squamous cell lesions of suspected HPV origin (Condyloma, CA; Focal Epithelial Hyperplasia, FEH; Squamous Cell Papilloma, SQP) as well as in tumors thought to be unrelated to HPV (Fibrous Hyperplasia, FH; Papillary Hyperplasia, PH; True Fibroma, TF; Keratoacanthoma, KA), using the ANAE (acid alpha-naphthyl acetate esterase) technique. "
08/01/1984 - "A series of 191 oral mucosal tumors including those with suspected HPV (Human Papilloma Virus) etiology; squamous cell papilloma (SQP), condyloma acuminatum (CA), focal epithelial hyperplasia (FEH), as well as those regarded as unrelated to HPV; fibrous hyperplasia (FH), papillary hyperplasia (PH), and true fibroma (TF), were analyzed for HPV structural proteins (by indirect immunoperoxidase IP-PAP technique), for the presence of epithelial dysplasia, and for the cellular composition (B and T lymphocytes, mononuclear phagocytes, (MPS cells] of their local inflammatory cell infiltrates using ANAE-(acid alpha-naphthyl acetate esterase) stain. "
|7.||HLA-DR4 Antigen (HLA DR4 Antigen)IBA
|8.||Vitamin A (Retinol)FDA LinkGeneric
06/01/1979 - "Support for its specificity to fibropapilloma derived bovine papilloma virus comes from (I) the absence of transformation associated changes following inoculations of normal bovine skin, bovine teat papilloma, bovine teat focal epithelial hyperplasia lesion and canine papilloma derived suspensions; (2) in vitro transformation occurs when CsCl purified fibropapilloma-derived BPV is used; (3) in vitro transformation experiments reported here parallel in vivo transmission of fibropapillomas described elsewhere using the same extracts; (4) the time-temperature inactivation of BPV using in vitro transformation parallels in vivo results and is similar to that reported for other papovaviruses; (5) BPV in vitro transformed cells are tumorigenic in nude mice and increase in vivo resistance in calves to subsequent challenge with fibropapilloma derived virus; (6) inhibition of in vitro transformation by bovine papilloma virus occurs when sera from calves bearing regressing fibropapillomas are used in conjunction with complement; (7) transformation inhibition activity may be adsorbed from high titre sera using BPV-induced tumour cells or in vitro transformed cells but not using various virus suspensions. "
|10.||Messenger RNA (mRNA)IBA
|3.||Laser Therapy (Surgery, Laser)
|4.||Highly Active Antiretroviral Therapy (HAART)
05/01/2010 - "We describe a case of focal epithelial hyperplasia in an HIV-seropositive child receiving highly active antiretroviral therapy, who was successfully treated by using diode laser ablation."
05/01/2010 - "HIV-seropositive subjects have a higher prevalence of oral human papillomavirus (HPV) infections than immunocompetent subjects; and paradoxically, the introduction of highly active antiretroviral therapy for treatment of HIV-seropositive subjects is associated with increased frequency of focal epithelial hyperplasia. "
05/01/2010 - "Focal epithelial hyperplasia (Heck disease) related to highly active antiretroviral therapy in an HIV-seropositive child. "